From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Stroke>
  4. Archives

Stroke: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 376-400 of 711 are shown

Predicting Stroke in Patients with Asymptomatic Carotid Stenosis?

Patients who already have CT evidence of silent embolic infarcts are most likely to benefit from surgery.

USPSTF Recommends Aspirin to Prevent MI in Men, Stroke in Women

The task force revised its 2002 recommendations, primarily based on new data for women.

Statins and Venous Thrombosis

Recent studies confirm that statins lower risk for VT and suggest that the agents could aid in managing venous disease.

Dronedarone — A New Option for Atrial Fibrillation?

A new drug promises efficacy and safety for AF patients.

Recanalization of Spontaneous Carotid Artery Dissection

Patients with no symptoms or signs of ischemia or without complete occlusions fared better than those with ischemia or occlusions.

Pregnancy-Associated Migraines Linked to Stroke

Peripartum migraines were strongly associated with incidence of ischemic stroke.

Got Atrial Fibrillation? Pick Your Poison and Your Endpoint

In ACTIVE A, clopidogrel plus aspirin reduced the risk for stroke compared with aspirin alone, but at a cost of increased major hemorrhage.

TIPS for Reducing Cardiovascular Risk

In a large feasibility trial, one small pill had favorable effects on many important risk markers.

At Risk for Stroke? Not Me!

Women at excess risk for stroke were unable to list most stroke warning signs and considered their own risk to be comparable to that of other women.

What Dose of Aspirin Should I Be Taking?

A post hoc trial data analysis suggests that low doses are better than high doses, especially in patients taking clopidogrel.

Scoring System to Stratify 10-Year Risk for Atrial Fibrillation

An online scoring system and online interactive risk calculator can be applied readily in primary care practices.

Strokes in Patients with Cancer

This broad review provides a solid framework for evaluating stroke in cancer patients but finds insufficient evidence to guide prevention and treatment.

Treatment-Mediated Change in HDL Cholesterol Levels and CHD Risks

Lowering LDL levels yielded benefit; raising HDL levels did not.

Health-Related Behaviors and Stroke Risk

Stroke prevention involves not only treating risk factors, but also encouraging patients to embrace health-related behaviors.

Prasugrel vs. Clopidogrel After Myocardial Infarction

Prasugrel was more effective for preventing ischemic events in patients who underwent percutaneous coronary interventions.

Emerging Perspectives: Diabetes and the Brain

Recent studies examine the importance of glucose to brain functioning in elders.

Benefits of Urgent Evaluation and Treatment for TIA and Minor Stroke

Early neurological assessment and treatment is cost-effective and prevents long-term disability.

Critical Role for a Particular Immune Cell in Acute Ischemic Stroke

Could the size of cerebral infarcts be limited by dampening the immune response?

Resting Heart Rate and Adverse Coronary Events in Women

Higher resting heart rate was associated independently with incidence of MI or coronary death.

Behavioral Disturbance in CADASIL

Mood disorders are common in these patients but have been characterized inconsistently in published reports.

Outcome Following Warfarin-Associated Intracerebral Hemorrhage

What factors affect outcome, and which patients with WICH should be restarted on warfarin?

How Does HT Affect the Brains of Older Menopausal Women?

Subclinical cerebrovascular disease and regional decreases in brain volume could contribute to HT-associated cognitive decline.

Review of Treatments for Cervical Artery Dissection

A systematic review finds a lack of high-quality data; available evidence suggests no difference between anticoagulant and antiplatelet therapy.

Desmoteplase Shows No Benefit for Treatment of Ischemic Stroke

When given within 3 to 9 hours after symptom onset, IV desmoteplase was no better than placebo.

Gene Variants Affect Metabolism of Clopidogrel — And Clinical Outcomes

Alleles that lower metabolism of clopidogrel also are linked to adverse cardiovascular outcomes.

Items 376-400 of 711 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.